quinta-feira, 8 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 27, 2026

Top Research Reports for Broadcom, Oracle & Mastercard

View original at finance.yahoo.com
Top Research Reports for Broadcom, Oracle & Mastercard Tuesday, January 27, 2026 The Zacks Research Daily presents the best research output of our analyst team…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Halliburton's offshore project portfolio strengthens its market position but challenges with the SAP migration project may affect near-term earnings potential

    80% confidence
  • Geospace Technologies Smart Water remains the core growth driver, posting 10.4% fiscal 2025 revenue growth on rising Hydroconn and Aquana adoption

    80% confidence
  • Oracle's Fiscal 2026 guidance indicates continued cloud acceleration but execution risks around data center capacity expansion warrant monitoring

    80% confidence
  • PulteGroup is hurting from weak consumer confidence and ongoing affordability challenges and elevated sales incentives and cost pressures are denting margins

    80% confidence
  • Gencor Industries ended fiscal 2025 with $136.3 million in cash and marketable securities and no debt

    80% confidence
  • Doximity leverages unmatched physician reach and AI-driven tools to solidify its role as healthcare's essential B2B engagement platform with strong profitability

    80% confidence
  • Gencor Industries fiscal 2025 gross margin remained stable at 27.5% and operating income rose 2.4%

    80% confidence
  • Mastercard rebates and incentives increased 15% YoY in the first nine months of 2025

    80% confidence
  • Broadcom is experiencing strong momentum fueled by growth in AI semiconductors and continued success with its VMware integration

    80% confidence
  • Mastercard net revenues rose 16% YoY in the first nine months of 2025

    80% confidence
  • Mastercard paid dividends of $2.1 billion in the first nine months of 2025

    80% confidence
  • Broadcom expects first-quarter fiscal 2026 AI revenues to double to $8.2 billion

    80% confidence
  • ADM Nutrition revenues rose 4.6% while segment operating profit grew 24% on robust Flavors portfolio in Q3

    80% confidence
  • Broadcom's gross margin in the fiscal first quarter is expected to contract sequentially and high debt level is a headwind

    80% confidence
  • Interactive Brokers' efforts to expand product suite and develop proprietary software will likely aid top line and help garner market share

    80% confidence
  • Oracle's cloud infrastructure business demonstrates accelerating revenue growth supported by strategic partnerships and competitive pricing

    80% confidence
  • Mastercard expects adjusted operating expenses to witness high-end of mid-teens YoY growth in 2025

    80% confidence
  • Oracle's ongoing transition from license revenue to subscription models creates near-term earnings volatility

    80% confidence
  • Competition from hyperscalers remains intense for Oracle, potentially pressuring margins

    80% confidence
  • Devon Energy results are likely to be pressured by competition to secure drilling rights and acquire assets, and new regulations could raise costs

    80% confidence
  • RLI Corp's exposure to cat losses has been weighing on underwriting profitability and higher expenses have been inducing margin contraction

    80% confidence
  • Microchip Technology's expanding product portfolio, solid demand for Gen 4 and Gen 5 data center products and AI investments are key catalysts

    80% confidence
  • Immunovant's steady progress across autoimmune programs is promising, but its narrow pipeline and fierce competition in the immunology space could hinder long-term growth

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Top Research Reports for Broadcom, Oracle & Mastercard — Source | Via News | pt.VIA.NEWS